Rare Causes of Pediatric Primary Adrenal Insufficiency: Data from a Large Nationwide Tunisian Cohort.

IF 2.9
Rania Khalfallah, Fakhri Kallabi, Delphine Mallet, Manel Guirat, Sana Kmiha, Faten Hadj Kacem, Imen Chabchoub, Hajer Aloulou, Clement Janot, Imene Boujelbene, Nourhene Gharbi, Nedia Charfi, Houda Kanoun, Neila Belguith, Yves Morel, Mongia Hachicha, Thouraya Kamoun, Mohamed Abid, Leila Keskes, Mouna Mnif, Hassen Kamoun, Florence Roucher-Boulez
{"title":"Rare Causes of Pediatric Primary Adrenal Insufficiency: Data from a Large Nationwide Tunisian Cohort.","authors":"Rania Khalfallah, Fakhri Kallabi, Delphine Mallet, Manel Guirat, Sana Kmiha, Faten Hadj Kacem, Imen Chabchoub, Hajer Aloulou, Clement Janot, Imene Boujelbene, Nourhene Gharbi, Nedia Charfi, Houda Kanoun, Neila Belguith, Yves Morel, Mongia Hachicha, Thouraya Kamoun, Mohamed Abid, Leila Keskes, Mouna Mnif, Hassen Kamoun, Florence Roucher-Boulez","doi":"10.1016/j.ando.2025.102461","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Primary adrenal insufficiency (PAI), a rare and potentially life-threatening disorder, involves genetic factors in over 80% of pediatric cases. Congenital adrenal hyperplasia (CAH) is common, while the prevalence of other genetic factors varies between countries.</p><p><strong>Objective: </strong>This study investigated the clinical and molecular genetic characteristics of a Tunisian PAI sub-cohort. Identifying causal variants is crucial for patient care, genetic counseling, follow-up and preventing complications. Determining variant prevalence will help in shaping a cost-effective molecular strategy in a country with limited resources.</p><p><strong>Patients and methods: </strong>Seventy-four patients from 65 families, with suspected congenital PAI, excluding CAH and autoimmune disease, were recruited. Clinical details were assessed by endocrinologists. Genetic analysis used a candidate gene approach (AAAS, ABCD1) and/or targeted enrichment with focused gene panels and next-generation sequencing (NGS). The pathogenicity of rare variants was assessed on in silico analysis.</p><p><strong>Results: </strong>The study achieved a diagnostic yield of 86% (56/65 families), confirming 45 patients with Allgrove syndrome (Triple A) and identifying 12 boys with adrenoleukodystrophy. The recurrent Maghreb variant (c.1331+ 1G>A) was identified within the AAAS gene. NGS revealed additional defects, including AAAS and ABCD1 variants in atypical cases (n=3). Other etiologies included MC2R (n = 1), NNT (n = 1), STAR (n = 2, 1 family), MCM4 (n= 1) variants; 14% remained undiagnosed, some with variants of uncertain significance.</p><p><strong>Conclusion: </strong>This study of Tunisia's largest PAI cohort confirmed the efficacy of the candidate gene approach. NGS significantly increased diagnostic yield (11%) and identified candidate variants. Achieving molecular diagnosis in almost 90% of children has implications for patient management, genetic counseling, monitoring and the prevention of complications.</p>","PeriodicalId":93871,"journal":{"name":"Annales d'endocrinologie","volume":" ","pages":"102461"},"PeriodicalIF":2.9000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales d'endocrinologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ando.2025.102461","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Primary adrenal insufficiency (PAI), a rare and potentially life-threatening disorder, involves genetic factors in over 80% of pediatric cases. Congenital adrenal hyperplasia (CAH) is common, while the prevalence of other genetic factors varies between countries.

Objective: This study investigated the clinical and molecular genetic characteristics of a Tunisian PAI sub-cohort. Identifying causal variants is crucial for patient care, genetic counseling, follow-up and preventing complications. Determining variant prevalence will help in shaping a cost-effective molecular strategy in a country with limited resources.

Patients and methods: Seventy-four patients from 65 families, with suspected congenital PAI, excluding CAH and autoimmune disease, were recruited. Clinical details were assessed by endocrinologists. Genetic analysis used a candidate gene approach (AAAS, ABCD1) and/or targeted enrichment with focused gene panels and next-generation sequencing (NGS). The pathogenicity of rare variants was assessed on in silico analysis.

Results: The study achieved a diagnostic yield of 86% (56/65 families), confirming 45 patients with Allgrove syndrome (Triple A) and identifying 12 boys with adrenoleukodystrophy. The recurrent Maghreb variant (c.1331+ 1G>A) was identified within the AAAS gene. NGS revealed additional defects, including AAAS and ABCD1 variants in atypical cases (n=3). Other etiologies included MC2R (n = 1), NNT (n = 1), STAR (n = 2, 1 family), MCM4 (n= 1) variants; 14% remained undiagnosed, some with variants of uncertain significance.

Conclusion: This study of Tunisia's largest PAI cohort confirmed the efficacy of the candidate gene approach. NGS significantly increased diagnostic yield (11%) and identified candidate variants. Achieving molecular diagnosis in almost 90% of children has implications for patient management, genetic counseling, monitoring and the prevention of complications.

儿童原发性肾上腺功能不全的罕见原因:来自突尼斯全国大队列的数据。
背景:原发性肾上腺功能不全(PAI)是一种罕见且可能危及生命的疾病,在80%以上的儿科病例中涉及遗传因素。先天性肾上腺增生症(CAH)是常见的,而其他遗传因素的患病率因国家而异。目的:本研究探讨突尼斯PAI亚队列的临床和分子遗传学特征。确定因果变异对患者护理、遗传咨询、随访和预防并发症至关重要。确定变异流行率将有助于在资源有限的国家制定具有成本效益的分子战略。患者和方法:来自65个家庭的74例疑似先天性PAI患者,不包括CAH和自身免疫性疾病。临床细节由内分泌学家评估。遗传分析采用候选基因方法(AAAS, ABCD1)和/或利用聚焦基因面板和下一代测序(NGS)进行靶向富集。对罕见变异的致病性进行了计算机分析。结果:本研究的诊断率为86%(56/65个家庭),确诊45例Allgrove综合征(Triple a),确诊12例男孩肾上腺脑白质营养不良。在AAAS基因中鉴定出复发性Maghreb变异(c.1331+ 1G>A)。NGS还发现了其他缺陷,包括非典型病例中的AAAS和ABCD1变异(n=3)。其他病因包括MC2R (n= 1)、NNT (n= 1)、STAR (n= 2, 1个家族)、MCM4 (n= 1)变异;14%仍未确诊,其中一些有不确定意义的变异。结论:突尼斯最大的PAI队列研究证实了候选基因方法的有效性。NGS显著提高了诊断率(11%)并确定了候选变异。在近90%的儿童中实现分子诊断对患者管理、遗传咨询、监测和预防并发症具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信